News & Views
Subsidiary Located to Access Biotech Ecosystem
Feb 22 2019
A Barcelona-based company specialising in the development of new drugs for orphan diseases has created a fully owned subsidiary in Belgium. Minoryx Therapeutics’ new business located in Brussels South Biopark (Charleroi), is leveraging the local biotech ecosystem to lead the research and development of MIN-102 in new orphan central nervous system (CNS) indications and will play an important role in the development of the company. Minoryx is recruiting several R&D positions for its Belgian site.
Minoryx recently announced a major Series B funding round led by the Belgian Fund+, joined by the public Belgian players SFPI-FPIM, S.R.I.W. and Sambrinvest, in addition to all Series A investors (Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi Ventures, Caixa Capital Risc and HealthEquity). The present extension of the company will further reinforce the link between Spain and Belgium, in particular with the Walloon ecosystem of the Brussels South Biopark.
“We are very excited to be expanding our operations to Belgium, benefiting from local experience in growing biotech companies as well as starting a relationship with Belgian VCs and public investors,” said Marc Martinell, CEO of Minoryx. “With major Belgian investors participating in our recent €21.3M Series B funding round, we believe that we have an excellent opportunity to tap into a very attractive biotech ecosystem and reinforce our growth.
“Minoryx brings a unique and promising approach to addressing the high unmet medical need in this field of rare diseases of genetic origin,” said Francois Fontaine of SFPI-FPIM.
“We are delighted that the company decided to set up its second base in Wallonia, from where it will oversee key research operations,” said Gery Lefebvre of S.R.I.W.
“We gladly welcome Minoryx, which reinforces and catalyzes our CNS drug development ecosystem,” commented Florence Bosco, CEO Brussels South Biopark Dev SA.
Digital Edition
International Labmate 49.6 - Sept 2024
September 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - From R&D to QC, making NMR accessible for everyone: Putting NMR...
View all digital editions
Events
Sep 22 2024 Messina, Italy
19th Confocal Raman Imaging Symposium
Sep 23 2024 Ulm, Germany
Sep 24 2024 Kielce, Poland
WoTS - World of Technology and Science
Sep 24 2024 Utrecht, Holland
Sep 25 2024 Frankfurt am Main, Germany